Pulmonx
LUNG
113 hedge funds and large institutions have $294M invested in Pulmonx in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 22 closing their positions.
33% more capital invested
Capital invested by funds: $220M → $294M (+$73.5M)
31% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 29
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
2% more funds holding
Funds holding: 111 → 113 (+2)
1.34% more ownership
Funds ownership: 89.5% → 90.84% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
100% less call options, than puts
Call options by funds: $10K | Put options by funds: $2.05M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.28M |
| 2 |
ACM
Altium Capital Management
New York
|
+$3.62M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$2.67M |
| 4 |
Morgan Stanley
New York
|
+$2.3M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$5.29M |
| 2 |
Millennium Management
New York
|
-$2.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.53M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.37M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.24M |
LUNG Hedge Fund Activity: Q3 2024 in Review
113 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q3 2024, worth a combined $294M — up 33% from $220M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new LUNG positions and 22 closed out — a net gain of 5 holders — while 38 added to existing stakes and 29 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $4.28M. The largest seller was Victory Capital Management, exiting entirely with an estimated $5.29M sold.
- 113 institutional investors held Pulmonx (LUNG) as of Q3 2024, up from 111 in Q2 2024.
- Funds reported $294M of Pulmonx stock for Q3 2024, up 33% quarter-over-quarter.
- 27 funds opened new Pulmonx positions in Q3 2024 and 22 closed out, a net change of +5 holders.
- The largest Pulmonx buyer in Q3 2024 was Fidelity Investments, an estimated $4.28M added.
- The largest Pulmonx seller in Q3 2024 was Victory Capital Management, an estimated $5.29M sold.
Based on aggregated 13F filings for Q3 2024.